AC Immunity Shares Jump 18% After Fast-Track Designation on Alzheimer's Treatment
27 6월 2023 - 9:11PM
Dow Jones News
By Jeffrey T. Lewis
AC Immunity's shares rose 18% after the biopharmaceutical
company got fast-track designation for a treatment for Alzheimer's
Disease from the Food and Drug Administration.
Shares reached $2.33 in pre-market trading and were down 3% from
the end of last year through Monday's close.
The company said Tuesday before trading began that its
anti-amyloid beta active immunotherapy-candidate, ACI-24.060, got
the designation, which is intended to speed up the development and
review of drugs that treat serious conditions and fill an unmet
medical need.
The goal of the designation is to speed important new drugs
through the approval process and get them to patients as quickly as
possible, according to the FDA
Write to Jeffrey T. Lewis at jeffrey.lewis@wsj.com
(END) Dow Jones Newswires
June 27, 2023 07:56 ET (11:56 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
AC Immune (NASDAQ:ACIU)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
AC Immune (NASDAQ:ACIU)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
